You are here

Novel Home-Based and Low-Cost ECG Device for periodic evaluation of the presence of atrial fibrillation

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R42NR018316-01A1
Agency Tracking Number: R42NR018316
Amount: $136,516.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: 600
Solicitation Number: PA17-303
Timeline
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): 2018-07-06
Award End Date (Contract End Date): 2019-06-30
Small Business Information
8104 CAZENOVIA RD STE 2/3
Manlius, NY 13104-6700
United States
DUNS: 147035427
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JEANPHILIPPE COUDERC
 (585) 754-3397
 heartjpc@heart.rochester.edu
Business Contact
 JIM DEMASO
Phone: (315) 682-0272
Email: jimdemaso@msn.com
Research Institution
 UNIVERSITY OF ROCHESTER
 
ORPA 518 HYLAN BLDG., BOX 270140
ROCHESTER, NY 14627-0140
United States

 Nonprofit College or University
Abstract

Abstract
Atrial fibrillationAFprevalence is estimated toof the general population in the United
StatesA shockingtoaccording to studiesof patients with AF are unaware of their
diagnosissilent AFMost AF patients will suffer from congestive heart failure or and develop
thromboembolic events leading to a dramatic reduction of patientsquality of lifeand a
significant consumption of health care resourcesThereforeAF prevention represents one of
the most significant challenges of modern clinical cardiologyIn the proposed projectwe will
evaluate a novel concept of patient monitoring utilizing a home based device called theCardioMatWe will conduct a Phaseto design the prototype of the device and test the device in a
small cohort ofAF patientsThenwe propose to conduct a Phaseproject around a clinical
study in which we will enrollAF patients going through either radiofrequency ablation or
electrical cardioversion and monitor these patients at home using an ECG patch and the
proposed new technologyWe will follow these patients duringdays after their procedureThe primary goal of the study is to evaluate whether the proposed home device can reliably
detect the presence of AF and in an appropriate timely fashion Project NarrativeAtrial fibrillationAFprevalence is estimated toof the general population in the United
StatesA shockingof patients with AF are unaware of their diagnosis thereforewe plan to
develop a novel technology enabling home based monitoring of the electrical activity of the
heart for detecting the presence of AF

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government